Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy.
Alba Ariela BrandesAndrea ArdizzoniFabrizio ArtioliFederico CappuzzoLuigi CavannaGiovanni Luca FrassinetiAntonio FrassoldatiFrancesco LeonardiGiuseppe LongoAntonio MaestriDavide TassinariEnrico FranceschiVincenzo Di NunnoCarmine PintoPublished in: Future oncology (London, England) (2020)
Aim: To assess the measures applied to reduce the spread of coronavirus disease (COVID-19) and the timing of their application in medical oncology departments. Materials & methods: We surveyed all medical oncology departments from the Italian Emilia Romagna region via a multidomain questionnaire. The questions covered items on patients, healthcare workers, risk reduction measure and clinical trials. Results: A total of 12 centers involving 861 healthcare members joined the survey. The measures applied to patients and health workers partially converged in all the departments while major divergences were found in the clinical trials domain. High rate of COVID-19 infection occurred among medical doctors (21/208, 10.1%) and social care workers (13/110, 11.8%). Rate of infection among nurses was 5.7% (24/418). Conclusion: All measures able to reduce risk of COVID-19 infection must be applied in medical oncology departments. Early introduction of risk reduction measures may be a critical issue.
Keyphrases
- healthcare
- coronavirus disease
- clinical trial
- palliative care
- end stage renal disease
- newly diagnosed
- ejection fraction
- mental health
- sars cov
- peritoneal dialysis
- prognostic factors
- randomized controlled trial
- respiratory syndrome coronavirus
- squamous cell carcinoma
- health information
- young adults
- climate change
- phase ii
- patient reported
- social media
- lymph node metastasis
- squamous cell